These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12643277)

  • 21. SCOTCH: subtype A coreceptor tropism classification in HIV-1.
    Löchel HF; Riemenschneider M; Frishman D; Heider D
    Bioinformatics; 2018 Aug; 34(15):2575-2580. PubMed ID: 29554213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
    Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
    J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools.
    Chueca N; Garrido C; Alvarez M; Poveda E; de Dios Luna J; Zahonero N; Hernández-Quero J; Soriano V; Maroto C; de Mendoza C; García F
    J Med Virol; 2009 May; 81(5):763-7. PubMed ID: 19319937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
    Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
    Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of co-receptor usage of HIV-1 from genotype.
    Dybowski JN; Heider D; Hoffmann D
    PLoS Comput Biol; 2010 Apr; 6(4):e1000743. PubMed ID: 20419152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of genotypic tools for prediction of tropism in HIV-1 subtype C V3 loop sequences.
    Gupta S; Neogi U; Srinivasa H; Shet A
    Intervirology; 2015; 58(1):1-5. PubMed ID: 25573618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model.
    Skrabal K; Low AJ; Dong W; Sing T; Cheung PK; Mammano F; Harrigan PR
    J Clin Microbiol; 2007 Feb; 45(2):279-84. PubMed ID: 17122004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.
    Wang WK; Dudek T; Zhao YJ; Brumblay HG; Essex M; Lee TH
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5740-5. PubMed ID: 9576954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
    Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
    Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage.
    Masso M; Vaisman II
    BMC Bioinformatics; 2010 Oct; 11():494. PubMed ID: 20923564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development.
    Zhang C; Xu S; Wei J; Guo H
    Int J Infect Dis; 2009 Sep; 13(5):e212-6. PubMed ID: 19217335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
    Jansson M; Backström E; Scarlatti G; Björndal A; Matsuda S; Rossi P; Albert J; Wigzell H
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1405-14. PubMed ID: 11679153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIVCoR: A sequence-based tool for predicting HIV-1 CRF01_AE coreceptor usage.
    Hongjaisee S; Nantasenamat C; Carraway TS; Shoombuatong W
    Comput Biol Chem; 2019 Jun; 80():419-432. PubMed ID: 31146118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1.
    McDonald RA; Chang G; Michael NL
    J Hum Virol; 2001; 4(4):179-87. PubMed ID: 11694845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage.
    Bozek K; Lengauer T; Sierra S; Kaiser R; Domingues FS
    PLoS Comput Biol; 2013; 9(3):e1002977. PubMed ID: 23555214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm.
    Cashin K; Gray LR; Jakobsen MR; Sterjovski J; Churchill MJ; Gorry PR
    Retrovirology; 2013 Feb; 10():24. PubMed ID: 23446039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.